Skip to content
lifestyle.ketodash.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AlzeCure Pharma
AlzeCure Receives a USD 10 Million Upfront Payment and Completes Initial Transaction with Lilly
August 18, 2026
AlzeCure Receives a Total Upfront Payment of USD 12 million and Completes the Initial Transaction with QuantumCell
August 12, 2026
AlzeCure Pharma Resolves on a Directed Share Issue to QuantumCell
August 3, 2026
AlzeCure Publishes its Interim Report for January – March 2026
May 22, 2026
Adjusted Timeline for the Previously Communicated Rights Issue
May 20, 2026
AlzeCure Pharma Carries Out a Fully Secured Rights Issue of Approximately SEK 30.1 million
April 30, 2026
Last Patient has Completed AlzeCure’s Phase Ib Clinical Study with NeuroRestore ACD856
April 20, 2026
AlzeCure Pharma Publishes its Annual Report for 2025
April 8, 2026
AlzeCure Pharma to Present at Redeye Healthcare Day on April 14
April 7, 2026
AlzeCure Pharma to Present at Redeye Alzheimer’s Theme Event on April 9
April 1, 2026
1
2
Next Page
→